Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination
- PMID: 21875636
- PMCID: PMC3191314
- DOI: 10.1016/j.vaccine.2011.08.083
Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination
Abstract
Identification of host genetic determinants of measles vaccine-induced immunity can be used to design better vaccines and ultimately predict immune responses to vaccination. We performed a comprehensive candidate gene association study across 801 genetic markers in 56 cytokine/cytokine receptor genes, in a racially diverse cohort of 745 schoolchildren after two doses of MMR vaccine. Using linear regression methodologies we examined associations between SNPs/haplotypes and measles virus-specific immunity. Forty-eight significant SNP associations with variations in neutralizing antibodies and measles-specific IFNγ Elispot responses were identified (p<0.05). Our study replicated an important previously found association of a functional IL12B genetic variant rs3212227 with variations in measles-specific humoral immunity (p=0.037). Similarly, two previously reported promoter IL10 and IL2 polymorphisms (rs1800890 and rs2069762) demonstrated associations with measles-specific cellular immunity in Caucasians (p≤0.034). Multiple IL7R polymorphisms, including a non-synonymous functional SNP (rs6897932/Thr244Ile), were associated with humoral (p≤0.024) and/or cellular (IFNγ Elispot, p≤0.023) measles-specific immune responses in Caucasians, but not African-Americans. Haplotype level analysis confirmed the association of IL7R genetic variants with measles vaccine-induced immunity in the Caucasian group (global p-value=0.003). Our results validate previous findings and identify new plausible genetic determinants, including IL7R polymorphisms, regulating measles vaccine-induced immunity in a race-specific manner.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Current perspectives in assessing humoral immunity after measles vaccination.Expert Rev Vaccines. 2019 Jan;18(1):75-87. doi: 10.1080/14760584.2019.1559063. Epub 2018 Dec 26. Expert Rev Vaccines. 2019. PMID: 30585753 Free PMC article. Review.
-
Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.Vaccine. 2011 Nov 8;29(48):8988-97. doi: 10.1016/j.vaccine.2011.09.043. Epub 2011 Sep 20. Vaccine. 2011. PMID: 21939710 Free PMC article.
-
Replication of associations between cytokine and cytokine receptor single nucleotide polymorphisms and measles-specific adaptive immunophenotypic extremes.Hum Immunol. 2012 Jun;73(6):636-40. doi: 10.1016/j.humimm.2012.03.015. Epub 2012 Apr 12. Hum Immunol. 2012. PMID: 22504412 Free PMC article.
-
Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population.Tissue Antigens. 2008 Sep;72(3):211-20. doi: 10.1111/j.1399-0039.2008.01097.x. Tissue Antigens. 2008. PMID: 18715339 Free PMC article.
-
The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.Expert Rev Vaccines. 2013 Jan;12(1):57-70. doi: 10.1586/erv.12.134. Expert Rev Vaccines. 2013. PMID: 23256739 Free PMC article. Review.
Cited by
-
Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination.Viral Immunol. 2012 Feb;25(1):29-36. doi: 10.1089/vim.2011.0051. Epub 2012 Jan 12. Viral Immunol. 2012. PMID: 22239234 Free PMC article.
-
In-vitro characterization of novel and functional regulatory SNPs in the promoter region of IL2 and IL2R alpha in a Gabonese population.BMC Med Genet. 2012 Dec 7;13:117. doi: 10.1186/1471-2350-13-117. BMC Med Genet. 2012. PMID: 23217119 Free PMC article.
-
Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines.Immunogenetics. 2014 Nov;66(11):663-9. doi: 10.1007/s00251-014-0796-z. Epub 2014 Aug 21. Immunogenetics. 2014. PMID: 25139337 Free PMC article.
-
Current perspectives in assessing humoral immunity after measles vaccination.Expert Rev Vaccines. 2019 Jan;18(1):75-87. doi: 10.1080/14760584.2019.1559063. Epub 2018 Dec 26. Expert Rev Vaccines. 2019. PMID: 30585753 Free PMC article. Review.
-
Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes.Vaccine. 2012 Mar 9;30(12):2159-67. doi: 10.1016/j.vaccine.2012.01.025. Epub 2012 Jan 20. Vaccine. 2012. PMID: 22265947 Free PMC article.
References
-
- Poland GA, Ovsyannikova IG, Jacobson RM, Smith DI. Heterogeneity in vaccine immune response: The role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther. 2007;82(6):653–64. - PubMed
-
- Dhiman N, Ovsyannikova IG, Cunningham JM, Vierkant RA, Kennedy RB, Pankratz VS, et al. Associations between measles vaccine immunity and single nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis. 2007;195:21–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI033144-16/AI/NIAID NIH HHS/United States
- AI33144/AI/NIAID NIH HHS/United States
- R01 AI033144-06/AI/NIAID NIH HHS/United States
- R01 AI033144-17/AI/NIAID NIH HHS/United States
- R01 AI048793-04/AI/NIAID NIH HHS/United States
- 5UL1RR024150-03/RR/NCRR NIH HHS/United States
- R01 AI048793-03/AI/NIAID NIH HHS/United States
- R01 AI033144-11/AI/NIAID NIH HHS/United States
- R01 AI033144-09/AI/NIAID NIH HHS/United States
- R01 AI048793-07/AI/NIAID NIH HHS/United States
- R01 AI033144-10/AI/NIAID NIH HHS/United States
- R01 AI048793-01/AI/NIAID NIH HHS/United States
- R01 AI033144-12/AI/NIAID NIH HHS/United States
- R01 AI033144-13/AI/NIAID NIH HHS/United States
- R37 AI048793-12/AI/NIAID NIH HHS/United States
- R01 AI048793-10/AI/NIAID NIH HHS/United States
- R01 AI048793-06/AI/NIAID NIH HHS/United States
- R01 AI033144/AI/NIAID NIH HHS/United States
- R01 AI033144-18/AI/NIAID NIH HHS/United States
- R01 AI033144-07/AI/NIAID NIH HHS/United States
- R01 AI048793-08/AI/NIAID NIH HHS/United States
- R01 AI048793/AI/NIAID NIH HHS/United States
- UL1 RR024150/RR/NCRR NIH HHS/United States
- R37 AI048793-11/AI/NIAID NIH HHS/United States
- R01 AI033144-14A2/AI/NIAID NIH HHS/United States
- R01 AI033144-15/AI/NIAID NIH HHS/United States
- R01 AI033144-08/AI/NIAID NIH HHS/United States
- R01 AI048793-05/AI/NIAID NIH HHS/United States
- R01 AI048793-02/AI/NIAID NIH HHS/United States
- R37 AI048793/AI/NIAID NIH HHS/United States
- AI48793/AI/NIAID NIH HHS/United States
- R01 AI048793-09/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical